Brief by Shorts91 Newsdesk / 06:50am on 05 Oct 2024,Saturday Health & Wellness
Scientists at the University of Oxford are developing OvarianVax, the world’s first vaccine for ovarian cancer, which aims to eliminate the disease. This innovative jab trains the immune system to recognize early-stage ovarian cancer and could be offered preventatively on the NHS. Led by Professor Ahmed Ahmed, the research focuses on targeting over 100 proteins on cancer cells. With funding of up to £600,000 from Cancer Research UK, the team plans to conduct clinical trials in women with BRCA mutations and the general population, potentially transforming ovarian cancer treatment in the next five years.
